Shared Care & High Risk Medicines - COVID FAQs
To ensure that you are seeing the most up to date information, refresh the page by pressing Ctrl and F5 together.
- Which patients on high risk medicines should shield / self-isolate during COVID19? (77 kb)
- Should I stop DMARDs during COVID19? (117 kb)
- DMARD monitoring during COVID19 (482 kb)
- Riluzole (for MND) monitoring during COVID19 (422 kb)
- Clozapine monitoring during COVID19 (299 kb)
- Lithium monitoring during COVID 19 (522 kb)
- Prescribing advice for patients with dermatological conditions prescribed immunosupressive medications (117 kb)
- ADHD monitoring (children & young people) during COVID19 (375 kb)
- Prescribing advice for patients with gastrointestinal and liver conditions treated with drugs affecting the immune response (426 kb)
- Prescribing advice for patients with musculoskeletal and rheumatic conditions who require steroids (446 kb)
- Managing chronic kidney disease (CKD) during COVID (473 kb)
